Download PDF
Thorac Cardiovasc Surg 2009; 57(3): 183-185
DOI: 10.1055/s-2006-955886
Case Reports

© Georg Thieme Verlag KG Stuttgart · New York

Mediastinal Synovial Sarcoma

H. Katakura1 , 2 , T. Fukuse1 , I. Shiraishi1 , E. Hayatsu1 , K. Nishijo3 , J. Toguchida3 , Y. Nakashima4 , H. Wada1
  • 1Thoracic Surgery, Kyoto University, Kyoto, Japan
  • 2Respiratory Disease, Otsu Red-cross Hospital, Otsu, Japan
  • 3Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
  • 4Translational Clinical Oncology, Kyoto University, Kyoto, Japan
Further Information

Publication History

received September 14, 2006

Publication Date:
27 March 2009 (online)

    Permissions and Reprints All articles of this category

Abstract

Synovial sarcoma of the mediastinum is a rare neoplasm that has overlapping histological and immunophenotypic features with other tumors in the differential diagnosis. We describe a case of this disease. The tumor was located at the right side of the pericardium, where an FDG‐PET scan showed an uptake. It was resected, a resection which was complicated by the necessity of partially resecting the pericaridium and right middle lobe which were invaded by the tumor. The doubling time of the main tumor [1] was 11.8 days. The margin of the resected specimen was tumor-free both macro- and microscopically. Reverse transcription-PCR confirmed the diagnosis of synovial sarcoma. The patient rejected chemotherapy or radiation therapy, and had recurrent tumors only one month after the operation. Finally, she opted to have only palliative care and died 79 days after the operation.

Key words

Thoracic surgery - synovial sarcoma - mediastinal tumor

References

  • 1 Schwartz M. A biomathematical approach to clinical tumor growth.  Cancer. 1961;  14 1272-1294
    PubMedGoogle Scholar
  • 2 Enzinger F M, Weiss S W. Soft Tissue Tumors. 3rd ed. St. Louis; Mosby 1995
    Google Scholar
  • 3 dos Santos N R, de Bruijn D R, van Kessel A G. Molecular mechanisms underlying human synovial sarcoma development.  Genes Chromosomes Cancer. 2001;  30 1-14
    CrossrefPubMedGoogle Scholar
  • 4 Yano M, Toyooka S, Tsukuda K, Dote H, Morimoto Y, Ohata N. et al . SYT‐SSX fusion genes in synovial sarcoma of the thorax.  Lung Cancer. 2004;  44 391-397
    CrossrefPubMedGoogle Scholar
  • 5 Okamoto S, Hisaoka M, Daa T, Hatakeyama K, Iwamasa T, Hashimoto H. Primary pulmonary synovial sarcoma: a clinicopathologic, immunohistochemical, and molecular study of 11 cases.  Hum Pathol. 2004;  35 850-856
    CrossrefPubMedGoogle Scholar
  • 6 Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma.  Oncogene. 2001;  20 5755-5762
    CrossrefPubMedGoogle Scholar
  • 7 Trassard M, Le Doussal V, Hacene K, Terrier P, Ranchere D, Guillou L. et al . Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adults patients.  J Clin Oncol. 2001;  19 525-534
    PubMedGoogle Scholar
  • 8 Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma: a multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival.  Am J Surg Pathol. 1993;  17 33-44
    PubMedGoogle Scholar

MD Hiromichi Katakura

Department of Thoracic Surgery
Kyoto University

Sakyo-ku, Shogoin Kawahara-cho 54

Kyoto 606-8507

Japan

Phone: + 81 7 57 51 49 75

Fax: + 81 7 57 51 49 74

Email: katakura@otsu.jrc.or.jp

      >